A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer (Q36114964)

12 August 2017

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer (English)

1 reference

12 August 2017

multivariate statistics

1 reference

8

Blomqvist C

1 reference

12 August 2017

Sjöström J

1

1 reference

12 August 2017

Krajewski S

2

1 reference

12 August 2017

Franssila K

3

1 reference

12 August 2017

Niskanen E

4

1 reference

12 August 2017

Wasenius VM

5

1 reference

12 August 2017

Nordling S

6

1 reference

12 August 2017

Reed JC

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

78

1 reference

12 August 2017

6

1 reference

12 August 2017

812-815

1 reference

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Predictive factors for response to cytotoxic treatment in advanced breast cancer: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062970

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

2 July 2018

1 reference

12 December 2020

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer

1 reference

12 December 2020

Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration

1 reference

12 December 2020

Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.584

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

9743306

1 reference